nach oben

European Journal of Nuclear Medicine and Molecular Imaging

Erschienen in:

23.03.2021 | Letter to the Editor

Deauville score evaluation of interim PET/CT in primary mediastinal large B-cell lymphoma

verfasst von: Wei Qin, Xufeng Jiang, Jianhua You, Rui Guo, Qing Shi, Lei Dong, Rong Shen, Shu Cheng, Pengpeng Xu, Ying Qian, Biao Li, Li Wang, Weili Zhao

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 11/2021

Einloggen, um Zugang zu erhalten

Excerpt

Dear Sir, …

Lazarovici J, Terroir M, Arfi-Rouche J, Michot JM, Mussot S, Florea V, et al. Poor predictive value of positive interim FDG-PET/CT in primary mediastinal large B-cell lymphoma. Eur J Nucl Med Mol Imaging. 2017;44:2018–24.CrossRef

Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127:2375–90.CrossRef

Barrington SF, Mikhaeel NG, Kostakoglu L, Meignan M, Hutchings M, Müeller SP, et al. Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group. J Clin Oncol. 2014;32:3048–58.CrossRef

Meignan M, Gallamini A, Meignan M, Gallamini A, Haioun C. Report on the first international workshop on interim-PET-scan in lymphoma. Leuk Lymphoma. 2009;50:1257–60.CrossRef

Zinzani PL, Ribrag V, Moskowitz CH, Michot JM, Kuruvilla J, Balakumaran A, et al. Safety and tolerability of pembrolizumab in patients with relapsed/refractory primary mediastinal large B-cell lymphoma. Blood. 2017;130:267–70.CrossRef

Armand P, Rodig S, Melnichenko V, Thieblemont C, Bouabdallah K, Tumyan G, et al. Pembrolizumab in relapsed or refractory primary mediastinal large B-cell lymphoma. J Clin Oncol. 2019;37:3291–9.CrossRef

Neelapu SS, Locke FL, Bartlett NL, Lekakis LJ, Miklos DB, Jacobson CA, et al. Axicabtagene ciloleucel CAR T-cell therapy in refractory large B-cell lymphoma. N Engl J Med. 2017;377:2531–44.CrossRef

Kochenderfer JN, Dudley ME, Kassim SH, Somerville RP, Carpenter RO, Stetler-Stevenson M, et al. Chemotherapy-refractory diffuse large B-cell lymphoma and indolent B-cell malignancies can be effectively treated with autologous T cells expressing an anti-CD19 chimeric antigen receptor. J Clin Oncol. 2015;33:540–9.CrossRef

Titel: Deauville score evaluation of interim PET/CT in primary mediastinal large B-cell lymphoma
verfasst von: Wei Qin
Xufeng Jiang
Jianhua You
Rui Guo
Qing Shi
Lei Dong
Rong Shen
Shu Cheng
Pengpeng Xu
Ying Qian
Biao Li
Li Wang
Weili Zhao
Publikationsdatum: 23.03.2021
Verlag: Springer Berlin Heidelberg
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 11/2021
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI: https://doi.org/10.1007/s00259-021-05310-6

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Deauville score evaluation of interim PET/CT in primary mediastinal large B-cell lymphoma

Excerpt

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 11/2021

Stereotactic radiotherapy to oligoprogressive lesions detected with 68Ga-PSMA-PET/CT in castration-resistant prostate cancer patients

Specific and non-specific binding of a tracer for the translocator-specific protein in schizophrenia: an [11C]-PBR28 blocking study

Segmentation of white matter hyperintensities on 18F-FDG PET/CT images with a generative adversarial network

A novel deep-learning–based approach for automatic reorientation of 3D cardiac SPECT images

A phase I study of a PARP1-targeted topical fluorophore for the detection of oral cancer

Neuropathological correlation supports automated image-based differential diagnosis in parkinsonism